Tumor-Specific EphA2 Receptor Tyrosine Kinase Inhibits Anti-Tumor Immunity by Recruiting Suppressive Myeloid Populations in Murine Models of Non-Small Cell Lung Cancer
Eileen Shiuan(Vanderbilt University), Dana M. Brantley‐Sieders(Vanderbilt University Medical Center)
Cited by 2
Related Papers
The receptor tyrosine kinase EphA2 promotes mammary adenocarcinoma tumorigenesis and metastatic progression in mice by amplifying ErbB2 signaling
|Journal of Clinical Investigation|2008|276
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
|Oncogene|2017|95
mTOR Directs Breast Morphogenesis through the PKC-alpha-Rac1 Signaling Axis
|PLoS Genetics|2015|47
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
|F1000Research|2020|16
Host deficiency in ephrin-A1 inhibits breast cancer metastasis
|F1000Research|2020|15